FI850940A0 - Foerfarande foer inaktivering av foeroekningsdugliga filterbara sjukdomsalstrare i blodprodukter. - Google Patents
Foerfarande foer inaktivering av foeroekningsdugliga filterbara sjukdomsalstrare i blodprodukter.Info
- Publication number
- FI850940A0 FI850940A0 FI850940A FI850940A FI850940A0 FI 850940 A0 FI850940 A0 FI 850940A0 FI 850940 A FI850940 A FI 850940A FI 850940 A FI850940 A FI 850940A FI 850940 A0 FI850940 A0 FI 850940A0
- Authority
- FI
- Finland
- Prior art keywords
- blood products
- sjukdomsalstrare
- inaktivering
- foeroekningsdugliga
- filterbara
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/04—Heat
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
- Eye Examination Apparatus (AREA)
- Filtering Of Dispersed Particles In Gases (AREA)
- Control Of El Displays (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Networks Using Active Elements (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT79284 | 1984-03-09 | ||
AT0079284A AT385657B (de) | 1984-03-09 | 1984-03-09 | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten |
AT0323784A AT389815B (de) | 1984-03-09 | 1984-10-11 | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten |
AT323784 | 1984-10-11 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI850940A0 true FI850940A0 (fi) | 1985-03-08 |
FI850940L FI850940L (fi) | 1985-09-10 |
FI81720B FI81720B (fi) | 1990-08-31 |
FI81720C FI81720C (fi) | 1990-12-10 |
Family
ID=25593930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI850940A FI81720C (fi) | 1984-03-09 | 1985-03-08 | Foerfarande foer inaktivering av oekningsbenaegna filterbara sjukdomsalstrare i blodprodukter. |
Country Status (9)
Country | Link |
---|---|
US (1) | US4640834A (fi) |
EP (1) | EP0159311B1 (fi) |
JP (1) | JPH0739348B2 (fi) |
AT (2) | AT389815B (fi) |
CA (1) | CA1239583A (fi) |
DE (1) | DE3569473D1 (fi) |
DK (1) | DK162966C (fi) |
ES (1) | ES8802273A1 (fi) |
FI (1) | FI81720C (fi) |
Families Citing this family (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0669961B2 (ja) * | 1984-09-25 | 1994-09-07 | 株式会社ミドリ十字 | 免疫グロブリンの加熱処理方法 |
AT390001B (de) * | 1984-09-28 | 1990-03-12 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern |
DE3577801D1 (de) * | 1985-08-05 | 1990-06-28 | Immuno Ag | Verfahren zur herstellung von praeparationen auf basis von blutgerinnungsfaktoren. |
EP0225581A3 (en) * | 1985-11-30 | 1989-05-24 | Green Cross Corporation | Method for the heat-treatment of immunoglobulins and immunoglobulin product |
DK595285D0 (da) * | 1985-12-20 | 1985-12-20 | Nordisk Gentofte | Injicerbart og varmebehandet igg-praeparat og fremgangsmaade til fremstilling af samme |
AT390374B (de) * | 1986-03-18 | 1990-04-25 | Schwab & Co Gmbh | Verfahren zum pasteurisieren von plasmaprotein und plasmaproteinfraktionen |
US4948877A (en) * | 1986-04-08 | 1990-08-14 | Miles Laboratories, Inc. | Preparation of retrovirus-free immunoglobulins |
US4762714A (en) * | 1986-04-08 | 1988-08-09 | Miles Laboratories, Inc. | Preparation of retrovirus-free immunoglobulins |
US5419906A (en) * | 1986-04-08 | 1995-05-30 | Miles Inc. | Preparation of human immunoglobulin free of hepatitis C |
US5159064A (en) * | 1986-04-08 | 1992-10-27 | Miles Inc. | Preparation of virus-free antibodies |
JPH0662436B2 (ja) * | 1986-05-19 | 1994-08-17 | 株式会社ミドリ十字 | 静注用免疫グロブリン製剤の製造方法 |
US5248767A (en) * | 1986-06-11 | 1993-09-28 | Behringwerke Aktiengesellschaft | Process for the preparation of a pasteurized immunoglobulin preparation using ethanol |
AT391808B (de) * | 1986-11-03 | 1990-12-10 | Immuno Ag | Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion |
AU2251288A (en) * | 1987-05-15 | 1988-12-06 | Alan I. Rubinstein | Sequential improved method for treatment of human blood- clotting factor products |
FR2618784B1 (fr) * | 1987-07-30 | 1990-04-06 | Lille Transfusion Sanguine | Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique |
US5260420A (en) * | 1987-07-30 | 1993-11-09 | Centre Regional De Transfusion Sanguine De Lille | Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof |
JP2613409B2 (ja) * | 1987-11-20 | 1997-05-28 | 株式会社ミドリ十字 | 抗エイズウイルス抗体陽性静注用免疫グロブリン製剤の製造方法 |
AT391809B (de) * | 1988-01-12 | 1990-12-10 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutplasmaprodukten |
US5484396A (en) * | 1988-11-17 | 1996-01-16 | Naficy; Sadeque S. | Method and device for treatment of HIV infections and AIDS |
AT395597B (de) * | 1991-01-25 | 1993-01-25 | Immuno Ag | Reagens zur bestimmung von faktor viii-aktivitaet |
AT402261B (de) * | 1991-01-25 | 1997-03-25 | Immuno Ag | Komplex enthaltend den gerinnungsfaktor ix |
AT402891B (de) * | 1991-06-20 | 1997-09-25 | Immuno Ag | Verfahren zur herstellung eines inaktivierten blutproduktes |
AT402262B (de) * | 1991-06-20 | 1997-03-25 | Immuno Ag | Arzneimittel enthaltend aktiviertes protein c |
AT398079B (de) * | 1991-11-04 | 1994-09-26 | Immuno Ag | Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung |
AT399818B (de) * | 1992-04-24 | 1995-07-25 | Immuno Ag | Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation |
JP3133338B2 (ja) * | 1992-12-16 | 2001-02-05 | イムノ・アクチエンゲゼルシャフト | ウイルス的に安全な生物学的組成物の調製方法 |
DE4320294A1 (de) * | 1993-06-18 | 1994-12-22 | Immuno Ag | Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen |
DE4325872C1 (de) * | 1993-08-02 | 1994-08-04 | Immuno Ag | Virusinaktivierte Faktor Xa-Präparation |
AT402788B (de) * | 1993-08-03 | 1997-08-25 | Immuno Ag | Virussichere blutgerinnungsfaktor xiii-präparation |
DE4404625C2 (de) * | 1994-02-14 | 1996-10-17 | Ludwig Dr Baumgartner | Verfahren zur Inaktivierung thermolabiler Viren in biologischem Material unter Beibehaltung der kollagenen Eigenschaften |
DE4411143C2 (de) * | 1994-03-30 | 1996-08-01 | Immuno Ag | Thrombosemittel |
DE4416180C2 (de) * | 1994-05-06 | 1997-08-14 | Immuno Ag | Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen und Verfahren zur Herstellung dieses Präparats |
US6017891A (en) * | 1994-05-06 | 2000-01-25 | Baxter Aktiengesellschaft | Stable preparation for the treatment of blood coagulation disorders |
DE4416166C2 (de) * | 1994-05-06 | 1997-11-20 | Immuno Ag | Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen |
DE4424935C1 (de) * | 1994-07-14 | 1996-03-21 | Immuno Ag | Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung |
DE19521324C1 (de) * | 1995-06-12 | 1996-10-31 | Immuno Ag | Gewebeklebstoff und Verwendung desselben als Hämostyptikum |
DE19531637A1 (de) * | 1995-08-28 | 1997-03-06 | Immuno Ag | Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung |
US5863896A (en) | 1995-11-09 | 1999-01-26 | Immuno Ag | Evaluation of substances for altering and for increasing APC response |
US6005077A (en) * | 1995-11-10 | 1999-12-21 | Immuno Aktiengesellschaft | Use of von willebrand factor and pharmaceutical formulation |
DE19600939C1 (de) | 1996-01-12 | 1997-08-28 | Immuno Ag | Verfahren zur Trennung von IgG und IgA |
DK0796623T3 (da) * | 1996-03-20 | 2005-08-01 | Baxter Ag | Farmaceutisk præparat til behandling af blodkoagulationslidelser |
US6068838A (en) * | 1996-04-29 | 2000-05-30 | Baxter Aktiengesellschaft | Purified multimerase |
DE19617369A1 (de) * | 1996-04-30 | 1997-11-06 | Immuno Ag | Lagerstabile Fibrinogen-Präparate |
US6632648B1 (en) | 1996-05-14 | 2003-10-14 | Elan Drug Delivery Limited | Methods of terminal sterilization of fibrinogen |
US6066325A (en) * | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
US8603511B2 (en) | 1996-08-27 | 2013-12-10 | Baxter International, Inc. | Fragmented polymeric compositions and methods for their use |
US7435425B2 (en) | 2001-07-17 | 2008-10-14 | Baxter International, Inc. | Dry hemostatic compositions and methods for their preparation |
US8303981B2 (en) | 1996-08-27 | 2012-11-06 | Baxter International Inc. | Fragmented polymeric compositions and methods for their use |
AU5082698A (en) * | 1996-10-23 | 1998-05-15 | Oravax, Inc | Heat inactivation of viruses in antibody preparations |
AT405135B (de) * | 1997-01-17 | 1999-05-25 | Immuno Ag | Präparation umfassend thiolgruppen-hältige proteine |
AT404358B (de) | 1997-02-04 | 1998-11-25 | Immuno Ag | Verfahren zur chromatographischen reinigung bzw. fraktionierung von von willebrand-faktor aus einem vwf-hältigen ausgangsmaterial |
AT405485B (de) | 1997-05-28 | 1999-08-25 | Immuno Ag | Eine das vwf-propeptid enthaltende pharmazeutische präparation |
AT406120B (de) | 1997-08-28 | 2000-02-25 | Immuno Ag | Gewebekleber |
AT405739B (de) | 1997-09-19 | 1999-11-25 | Immuno Ag | Verfahren zur reinigung von antithrombin iii |
US6579537B2 (en) | 1999-02-12 | 2003-06-17 | Baxter Aktiengesellschaft | Method for producing fibronectin and fibrinogen compositions using a polyalkylene glycol and glycine or β-alanine |
DK2193809T3 (en) | 1999-02-22 | 2015-05-26 | Univ Connecticut | The albumin-free Factor VIII formulation |
AT410218B (de) | 1999-08-20 | 2003-03-25 | Baxter Ag | Verfahren zur herstellung eines qualitätsgesicherten pools biologischer proben |
FR2806910B1 (fr) * | 2000-04-03 | 2003-01-24 | Dolisos Lab | Procede d'inactivation virale de solutions hydro-alcooliques |
EP1148063A1 (de) * | 2000-04-18 | 2001-10-24 | Octapharma AG | Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung |
US7411006B2 (en) * | 2000-10-23 | 2008-08-12 | Shanbrom Technologies, Llc | Enhanced production of blood clotting factors and fibrin fabric |
US7795218B2 (en) | 2001-04-12 | 2010-09-14 | Bioaxone Therapeutique Inc. | ADP-ribosyl transferase fusion variant proteins |
US8834864B2 (en) * | 2003-06-05 | 2014-09-16 | Baxter International Inc. | Methods for repairing and regenerating human dura mater |
US7927626B2 (en) * | 2003-08-07 | 2011-04-19 | Ethicon, Inc. | Process of making flowable hemostatic compositions and devices containing such compositions |
EP2335650B1 (en) | 2003-12-11 | 2012-10-03 | Isto Technologies Inc. | Particulate cartilage system |
US8480757B2 (en) | 2005-08-26 | 2013-07-09 | Zimmer, Inc. | Implants and methods for repair, replacement and treatment of disease |
MX2008014847A (es) * | 2006-05-31 | 2009-04-30 | Baxter Int | Metodo para crecimiento interno en la celula dirigido y regeneracion controlada de los tejidos en la cirugia espinal. |
TWI436793B (zh) | 2006-08-02 | 2014-05-11 | Baxter Int | 快速作用之乾密封膠及其使用和製造方法 |
US8623842B2 (en) * | 2006-09-27 | 2014-01-07 | Hemostasis, Llc | Hemostatic agent and method |
US20080154233A1 (en) * | 2006-12-20 | 2008-06-26 | Zimmer Orthobiologics, Inc. | Apparatus for delivering a biocompatible material to a surgical site and method of using same |
US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
AU2008240191B2 (en) | 2007-04-12 | 2013-09-19 | Zimmer, Inc. | Compositions and methods for tissue repair |
ES2477271T3 (es) | 2007-08-13 | 2014-07-16 | Baxter International Inc. | Modulación por IVIG de quimioquinas para el tratamiento de la esclerosis múltiple, la enfermedad de Alzheimer y la enfermedad de Parkinson |
CN101842122B (zh) | 2007-10-30 | 2013-12-25 | 巴克斯特国际公司 | 再生性生物功能胶原生物基质用于治疗内脏或腔壁缺损的应用 |
JP5569398B2 (ja) | 2008-02-29 | 2014-08-13 | フェッローサン メディカル ディバイス エー/エス | 止血および/または創傷治癒を促進するための装置 |
US9061087B2 (en) * | 2008-03-04 | 2015-06-23 | Hemostasis, Llc | Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor |
MX339060B (es) | 2008-11-07 | 2016-05-09 | Baxter Int | Formulaciones del factor viii. |
US9039783B2 (en) | 2009-05-18 | 2015-05-26 | Baxter International, Inc. | Method for the improvement of mesh implant biocompatibility |
PT2442835E (pt) * | 2009-06-16 | 2015-03-23 | Baxter Healthcare Sa | Esponja hemostática |
US20110052663A1 (en) * | 2009-09-01 | 2011-03-03 | Hemostasis, Llc | Hemostatic Sponge with Enzyme and Method of Manufacture |
KR101811070B1 (ko) | 2009-12-16 | 2017-12-20 | 백스터 인터내셔널 인코포레이티드 | 지혈 스폰지 |
SA111320355B1 (ar) | 2010-04-07 | 2015-01-08 | Baxter Heathcare S A | إسفنجة لايقاف النزف |
US9084728B2 (en) | 2010-06-01 | 2015-07-21 | Baxter International Inc. | Process for making dry and stable hemostatic compositions |
KR101957625B1 (ko) | 2010-06-01 | 2019-03-12 | 백스터 인터내셔널 인코포레이티드 | 건조 및 안정한 지혈 조성물의 제조 방법 |
EP2575776B1 (en) | 2010-06-01 | 2018-05-30 | Baxter International Inc | Process for making dry and stable hemostatic compositions |
CA2851338C (en) | 2011-10-11 | 2019-11-05 | Baxter International Inc. | Hemostatic compositions |
JP6195569B2 (ja) | 2011-10-11 | 2017-09-13 | バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated | 止血組成物 |
DK2771027T3 (en) | 2011-10-27 | 2015-11-02 | Baxter Int | hemostatic compositions |
CN107551269A (zh) | 2012-02-29 | 2018-01-09 | 百深公司 | 周围神经的IgG刺激髓鞘再生 |
CA2865349C (en) | 2012-03-06 | 2021-07-06 | Ferrosan Medical Devices A/S | Pressurized container containing haemostatic paste |
CA2874290C (en) | 2012-06-12 | 2020-02-25 | Ferrosan Medical Devices A/S | Dry haemostatic composition |
US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
CN105358071B (zh) | 2013-06-21 | 2018-07-31 | 弗罗桑医疗设备公司 | 真空膨胀的干组合物和用于保留该干组合物的注射器 |
CA2928963C (en) | 2013-12-11 | 2020-10-27 | Ferrosan Medical Devices A/S | Dry composition comprising an extrusion enhancer |
WO2016058612A1 (en) | 2014-10-13 | 2016-04-21 | Ferrosan Medical Devices A/S | Dry composition for use in haemostasis and wound healing |
EP3237041B1 (en) | 2014-12-24 | 2020-01-29 | Ferrosan Medical Devices A/S | Syringe for retaining and mixing first and second substances |
BR112017027695A2 (pt) | 2015-07-03 | 2018-09-04 | Ferrosan Medical Devices As | seringa para retenção e mistura de primeira e segunda substâncias |
MX2020011866A (es) | 2018-05-09 | 2021-01-20 | Ferrosan Medical Devices As | Metodo para preparar una composicion hemostatica. |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3361732A (en) * | 1964-07-28 | 1968-01-02 | Dow Chemical Co | Method for concentration of blood protein solutions employing methanol and flash evaporation |
AT350726B (de) * | 1976-08-30 | 1979-06-11 | Immuno Ag | Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma |
US4250139A (en) * | 1979-02-01 | 1981-02-10 | Collagen Corporation | Microwave sterilization of dry protein |
AT359646B (de) * | 1979-04-19 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen |
DE2916711A1 (de) * | 1979-04-25 | 1980-11-06 | Behringwerke Ag | Blutgerinnungsfaktoren und verfahren zu ihrer herstellung |
US4440679A (en) * | 1980-03-05 | 1984-04-03 | Cutter Laboratories, Inc. | Pasteurized therapeutically active protein compositions |
DE3176491D1 (en) * | 1980-03-05 | 1987-11-26 | Miles Lab | Pasteurized therapeutically active protein compositions |
JPS572687A (en) * | 1980-06-06 | 1982-01-08 | Ajinomoto Co Inc | Preparation of l-isoleucine by fermentation |
AT368883B (de) * | 1980-07-22 | 1982-11-25 | Immuno Ag | Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen |
DE3043857A1 (de) * | 1980-11-21 | 1982-07-08 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ii und vii |
DE3045153A1 (de) * | 1980-11-29 | 1982-07-08 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x |
JPS57140724A (en) * | 1981-02-25 | 1982-08-31 | Green Cross Corp:The | Heat-treatment of aqueous solution containing cold insoluble globulin |
US4495278A (en) * | 1981-04-27 | 1985-01-22 | Baxter Travenol Laboratories, Inc. | Process for making novel blood clotting enzyme compositions |
JPS5874617A (ja) * | 1981-10-28 | 1983-05-06 | Green Cross Corp:The | 人由来血液凝固第7因子含有水溶液の加熱処理方法 |
US4456590B2 (en) * | 1981-11-02 | 1989-05-30 | Heat treatment of lyphilized blood clotting factor viii concentrate | |
US4481189A (en) * | 1982-04-14 | 1984-11-06 | New York Blood Center Inc. | Process for preparing sterilized plasma and plasma derivatives |
US4379085A (en) * | 1982-05-14 | 1983-04-05 | American National Red Cross | Heat stabilization of plasma proteins |
US4511556A (en) * | 1982-06-10 | 1985-04-16 | The United States Of America As Represented By The Department Of Health And Human Services | Inactivation of a lipid virus |
US4470986A (en) * | 1982-12-21 | 1984-09-11 | Ciba-Geigy Corporation | Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors |
-
1984
- 1984-10-11 AT AT0323784A patent/AT389815B/de not_active IP Right Cessation
-
1985
- 1985-02-18 AT AT85890044T patent/ATE42205T1/de not_active IP Right Cessation
- 1985-02-18 EP EP85890044A patent/EP0159311B1/de not_active Expired
- 1985-02-18 DE DE8585890044T patent/DE3569473D1/de not_active Expired
- 1985-02-26 US US06/705,691 patent/US4640834A/en not_active Expired - Lifetime
- 1985-03-04 ES ES540919A patent/ES8802273A1/es not_active Expired
- 1985-03-07 CA CA000475883A patent/CA1239583A/en not_active Expired
- 1985-03-08 DK DK107185A patent/DK162966C/da not_active IP Right Cessation
- 1985-03-08 FI FI850940A patent/FI81720C/fi not_active IP Right Cessation
- 1985-03-09 JP JP60047330A patent/JPH0739348B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK162966C (da) | 1992-05-25 |
JPS60215628A (ja) | 1985-10-29 |
ES8802273A1 (es) | 1988-05-01 |
DK107185A (da) | 1985-09-10 |
JPH0739348B2 (ja) | 1995-05-01 |
DE3569473D1 (en) | 1989-05-24 |
ES540919A0 (es) | 1988-05-01 |
EP0159311B1 (de) | 1989-04-19 |
ATA323784A (de) | 1989-07-15 |
DK162966B (da) | 1992-01-06 |
CA1239583A (en) | 1988-07-26 |
EP0159311A1 (de) | 1985-10-23 |
FI81720B (fi) | 1990-08-31 |
FI81720C (fi) | 1990-12-10 |
ATE42205T1 (de) | 1989-05-15 |
US4640834A (en) | 1987-02-03 |
DK107185D0 (da) | 1985-03-08 |
FI850940L (fi) | 1985-09-10 |
AT389815B (de) | 1990-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI850940L (fi) | Foerfarande foer inaktivering av foeroekningsdugliga filterbara sjukdomsalstrare i blodprodukter. | |
ES532075A0 (es) | Procedimiento para la inactivacion de germenes patogenos, capaces de reproducirse | |
DK0519901T3 (da) | Virusinaktiveret blodprodukt fremstillet ved behandling med varme og/eller detergent | |
ATE220929T1 (de) | Behandlung von biologischen materialen vor der fixierung | |
BR8207582A (pt) | Processo para producao de novas composicoes de enzima para coagulacao sang"uinea | |
IE55008B1 (en) | Heat treatment of lyophilized plasma fractions | |
ES2032316T3 (es) | Procedimiento para la esterilizacion de plasma o fracciones de plasma. | |
DE69024904T2 (de) | Herstellung von Polyolpolyestern | |
ATE301186T1 (de) | Verfahren zur sterilisation biologischer zusammensetzungen und das dabei erhaltene produkt | |
DE59001181D1 (de) | Verfahren zur entseuchung und aeroben stabilisierung von klaerschlamm. | |
DK272287A (da) | Fremgangsmaade til inaktivering af formeringsdygtige, filtrerbare sygdomsfremkaldere | |
ATE21824T1 (de) | Verfahren zur herstellung von und danach hergestelltes plasminogen. | |
AU568849B2 (en) | Inactivation of viruses in virus containing protein samples | |
US2189948A (en) | Sterilization of pancreatin | |
ATE359362T1 (de) | A-agarase und verfahren zur herstellung derselben | |
ATE125713T1 (de) | Verfahren zur inaktivierung der biologischen aktivität von dna. | |
SU1472508A1 (ru) | Способ определени активаторов плазминогена | |
NO170055C (no) | Fremgangsmaate for inaktivering av termisk foelsomme, patogene, blod-baarede virus i igg-preparater | |
JPS63107794A (ja) | 水の殺菌方法 | |
UA84549C2 (ru) | Способ обработки растительного материала, который содержит пектин |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: "IMMUNO" AKTIENGESELLSCHAFT FUER |